









Mercado
/
Acciones
/
nasdaq-hae
/

Haemonetics Corp

HAE

50.600USD

-0.550-1.08%

Cierre 09/19, 16:00（ET）Cotizaciones retrasadas 15 min

2.44BCap. mercado

14.92P/E TTM



Haemonetics Corp

50.600

-0.550-1.08%

Descripción general Compañía Finanzas Análisis

Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. The Company’s technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. The Company’s Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage and Transfusion Management products.

Información de la empresa

Símbolo de cotizaciónHAE

Nombre de la empresaHaemonetics Corp

Fecha de salida a bolsaOct 17, 1979

Director ejecutivoMr. Christopher A. Simon

Número de empleados3023

Tipo de seguridadOrdinary Share

Fin del año fiscalOct 17

Dirección125 Summer Street

CiudadBOSTON

Bolsa de valoresNYSE Consolidated

PaísUnited States of America

Código postal02110

Teléfono17818487100

Sitio Webhttps://www.haemonetics.com

Símbolo de cotizaciónHAE

Fecha de salida a bolsaOct 17, 1979

Director ejecutivoMr. Christopher A. Simon

Ejecutivos de la empresa

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Ms. Laurie A. Miller

Chief Human Resources Officer, Senior Vice President

28.24K

+12.76%

Mr. Charles J. Dockendorff, CPA

Independent Director

25.04K

+12.05%

Mr. Robert E. Abernathy

Independent Director

24.98K

+12.08%

Dr. Mark W. Kroll, Ph.D.

Independent Director

23.36K

+13.03%

Ms. Michelle L. Basil, J.D.

Executive Vice President, General Counsel

19.69K

+2.11%

Ms. Ellen M. Zane

Independent Chairman of the Board

19.37K

+16.15%

Mr. Michael J. Coyle

Independent Director

15.39K

+21.20%

Ms. Diane M. Bryant

Independent Director

7.13K

+60.75%

Mr. Roy Galvin

Executive Vice President, Chief Commercial Officer

3.39K

Mr. Frank W. Chan

Chief Operating Officer, Executive Vice President

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Ms. Laurie A. Miller

Chief Human Resources Officer, Senior Vice President

28.24K

+12.76%

Mr. Charles J. Dockendorff, CPA

Independent Director

25.04K

+12.05%

Mr. Robert E. Abernathy

Independent Director

24.98K

+12.08%

Dr. Mark W. Kroll, Ph.D.

Independent Director

23.36K

+13.03%

Ms. Michelle L. Basil, J.D.

Executive Vice President, General Counsel

19.69K

+2.11%

Ms. Ellen M. Zane

Independent Chairman of the Board

19.37K

+16.15%

Desglose de ingresos

Divisa: USDActualizado: dom., 6 de jul

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2021

FY2020

FY2019

Sin datos

Por regiónUSD

Nombre

Ganancia

Proporción

United States

1.01B

74.29%

Europe

175.66M

12.91%

Asia

92.31M

6.78%

Japan

62.41M

4.59%

other

19.54M

1.44%

Por negocio

Por región

Sin datos

Estadísticas de accionistas

Actualizado: mié., 27 de ago

Accionistas

Tipos de accionistas

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

11.56%

The Vanguard Group, Inc.

10.26%

Neuberger Berman, LLC

8.88%

Wellington Management Company, LLP

4.46%

State Street Global Advisors (US)

3.91%

Otro

60.94%

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

11.56%

The Vanguard Group, Inc.

10.26%

Neuberger Berman, LLC

8.88%

Wellington Management Company, LLP

4.46%

State Street Global Advisors (US)

3.91%

Otro

60.94%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

52.55%

Investment Advisor/Hedge Fund

49.82%

Hedge Fund

5.32%

Research Firm

4.12%

Bank and Trust

1.39%

Pension Fund

1.35%

Individual Investor

1.19%

Sovereign Wealth Fund

1.11%

Insurance Company

0.04%

Participación institucional

Actualizado: mar., 1 de jul

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q2

700

57.31M

118.95%

-4.19M

2025Q1

723

57.94M

120.44%

-3.07M

2024Q4

701

58.48M

116.40%

-1.44M

2024Q3

689

57.60M

112.60%

-1.51M

2024Q2

668

57.60M

113.31%

+3.07M

2024Q1

655

52.49M

103.35%

-1.26M

2023Q4

647

51.85M

102.19%

-3.31M

2023Q3

657

52.00M

102.54%

-4.11M

2023Q2

656

51.75M

102.38%

-4.68M

2023Q1

715

51.58M

102.24%

-8.44M

Actividad de los accionistas

Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

BlackRock Institutional Trust Company, N.A.

5.67M

11.79%

+31.09K

+0.55%

Mar 31, 2025

The Vanguard Group, Inc.

5.09M

10.59%

-80.50K

-1.56%

Mar 31, 2025

Neuberger Berman, LLC

4.35M

9.05%

-70.98K

-1.61%

Mar 31, 2025

Wellington Management Company, LLP

2.62M

5.46%

-1.32M

-33.38%

Mar 31, 2025

State Street Global Advisors (US)

1.92M

3.99%

-28.97K

-1.49%

Mar 31, 2025

River Road Asset Management, LLC

1.40M

2.9%

+1.04M

+295.76%

Mar 31, 2025

T. Rowe Price Investment Management, Inc.

2.20M

4.57%

-358.25K

-14.03%

Mar 31, 2025

Royce Investment Partners

1.16M

2.42%

+8.03K

+0.70%

Mar 31, 2025

Geode Capital Management, L.L.C.

1.22M

2.54%

+40.32K

+3.41%

Mar 31, 2025

Capital Research Global Investors

1.58M

3.28%

-2.66M

-62.79%

Mar 31, 2025

ETFs relacionados

Actualizado: sáb., 6 de sep

Nombre

Proporción

Harbor Human Capital Factor US Small Cap ETF

1.78%

SPDR S&P Health Care Equipment ETF

1.45%

First Trust Small Cap Growth AlphaDEX Fund

0.28%

Fidelity Small-Mid Multifactor ETF

0.15%

Global X Russell 2000 ETF

0.15%

Vanguard S&P Mid-Cap 400 Growth Index Fund

0.14%

Invesco Dynamic Buyback Achievers ETF

0.12%

Nuveen ESG Small-Cap ETF

0.11%

Vanguard S&P Mid-Cap 400 Value Index Fund

0.11%

SPDR S&P 400 Mid Cap Growth ETF

0.1%

Harbor Human Capital Factor US Small Cap ETF

Proporción1.78%

SPDR S&P Health Care Equipment ETF

Proporción1.45%

First Trust Small Cap Growth AlphaDEX Fund

Proporción0.28%

Fidelity Small-Mid Multifactor ETF

Proporción0.15%

Global X Russell 2000 ETF

Proporción0.15%

Vanguard S&P Mid-Cap 400 Growth Index Fund

Proporción0.14%

Invesco Dynamic Buyback Achievers ETF

Proporción0.12%

Nuveen ESG Small-Cap ETF

Proporción0.11%

Vanguard S&P Mid-Cap 400 Value Index Fund

Proporción0.11%

SPDR S&P 400 Mid Cap Growth ETF

Proporción0.1%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones

Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

KeyAI

